scispace - formally typeset
H

Hee-Won Jung

Researcher at University of Ulsan

Publications -  299
Citations -  8181

Hee-Won Jung is an academic researcher from University of Ulsan. The author has contributed to research in topics: Medicine & Sarcopenia. The author has an hindex of 46, co-authored 270 publications receiving 6820 citations. Previous affiliations of Hee-Won Jung include New Generation University College & Chung-Ang University.

Papers
More filters
Journal ArticleDOI

Multidimensional Frailty Score for the Prediction of Postoperative Mortality Risk

TL;DR: The multidimensional frailty score based on comprehensive geriatric assessment is more useful than conventional methods for predicting outcomes in geriatric patients undergoing surgery.
Journal ArticleDOI

Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.

TL;DR: The 2000 WHO classification has identified the truly aggressive meningiomas better than did the previous criteria and may help to avoid over-treatment of patients with an atypical mening ioma as, once the tumour has “declared itself” by recurrence and histological features, it becomes a tumour that is poorly amenable to current therapies.
Journal ArticleDOI

Surgical treatment of symptomatic Rathke cleft cysts: clinical features and results with special attention to recurrence.

TL;DR: R Rathke cleft cysts are associated with a variety of clinical presentations and sometimes confusing intraoperative and pathological findings, especially after a partial removal, as in cases with squamous metaplasia.
Journal ArticleDOI

Long-term outcome and growth rate of subtotally resected petroclival meningiomas: experience with 38 cases.

TL;DR: Subtotal resection with or without radiation or radiosurgery should be considered as a suitable treatment option for patients with petroclival meningiomas, especially the elderly, because the growth rate of residual tumors is low.
Journal ArticleDOI

Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy

TL;DR: Decreased muscle mass was associated with increased risk of grade 3–4 toxicity and poor prognosis in patients with stage III colon cancer and was maintained in subgroup analyses, especially in older and obese patients.